Q Synthesis LLC
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Updates

Advancing the Application of Immuno-Oncology to Improve Patient Care

10/16/2019

0 Comments

 
The rapid rate of breakthroughs in immuno-oncology (IO) continues to disrupt diagnostic processes and workflows in cancer care. As more patients with different types of cancers are treated with immune checkpoint inhibitor therapy, pathologists and laboratory professionals need to work closely with oncologists and other cancer clinicians to optimize IO biomarker testing and ensure that patients are treated with the right agents.

This live 1.5-hour CME multidisciplinary, interactive panel discussion will highlight practical ways to overcome barriers around IO biomarker testing, communication among members of the multidisciplinary cancer care team, and the use of immune checkpoint inhibitor therapy to improve patient care.
Advancing the Application of Immuno-Oncology to Improve Patient Care
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
www.qsynthesis.com
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Updates